Shares of ResMed Inc. RMD slipped 2.47% to $220.22 Wednesday, on what proved to be an all-around mixed trading session for ...

Resmed, a leader in sleep technology, unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful Monsters. To help ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

The medical device industry is undergoing a profound change in 2025, driven by advancements in generative AI and agentic AI.

Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

ResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the Medical-Products industry group. Boston Scientific, Penum ...

Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

Shares of ResMed Inc. RMD shed 4.58% to $225.79 Tuesday, on what proved to be an all-around rough trading session for the ...

Resmed, a leader in sleep technology, has unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful Monsters.